187 related articles for article (PubMed ID: 27050701)
1. A Novel Matrikine-Like Micro-Protein Complex (MPC) Technology for Topical Skin Rejuvenation.
Dreher F
J Drugs Dermatol; 2016 Apr; 15(4):457-64. PubMed ID: 27050701
[TBL] [Abstract][Full Text] [Related]
2. Pilot, Multicenter, Open-Label Evaluation of Safety, Tolerability and Efficacy of a Novel, Topical Multipotent Growth Factor Formulation for the Periorbital Region.
Sundaram H; Gold M; Waldorf H; Lupo M; Nguyen VL; Karnik J
J Drugs Dermatol; 2015 Dec; 14(12):1410-7. PubMed ID: 26659933
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of novel skin cream containing mixture of human growth factors and cytokines for skin rejuvenation.
Gold MH; Goldman MP; Biron J
J Drugs Dermatol; 2007 Feb; 6(2):197-201. PubMed ID: 17373178
[TBL] [Abstract][Full Text] [Related]
4. Human growth factor and cytokine skin cream for facial skin rejuvenation as assessed by 3D in vivo optical skin imaging.
Gold MH; Goldman MP; Biron J
J Drugs Dermatol; 2007 Oct; 6(10):1018-23. PubMed ID: 17966179
[TBL] [Abstract][Full Text] [Related]
5. Clinical Evidence of Dermal and Epidermal Restructuring from a Biologically Active Growth Factor Serum for Skin Rejuvenation.
Barone F; Bashey S; Woodin Jr. FW
J Drugs Dermatol; 2019 Mar; 18(3):290-295. PubMed ID: 30909351
[TBL] [Abstract][Full Text] [Related]
6. Global periorbital skin rejuvenation by a topical eye cream containing low molecular weight heparan sulfate (LMW-HS) and a blend of naturally derived extracts.
Colvan L; Fleck T; Vega VL
J Cosmet Dermatol; 2019 Apr; 18(2):530-538. PubMed ID: 30636356
[TBL] [Abstract][Full Text] [Related]
7. Clinical, histologic, and ultrastructural changes after use of human growth factor and cytokine skin cream for the treatment of skin rejuvenation.
Hussain M; Phelps R; Goldberg DJ
J Cosmet Laser Ther; 2008 Jun; 10(2):104-9. PubMed ID: 18569263
[TBL] [Abstract][Full Text] [Related]
8. Prediction, screening and characterization of novel bioactive tetrapeptide matrikines for skin rejuvenation.
Jariwala N; Ozols M; Eckersley A; Mambwe B; Watson REB; Zeef L; Gilmore A; Debelle L; Bell M; Bradley EJ; Doush Y; Keenan A; Courage C; Leroux R; Peschard O; Mondon P; Ringenbach C; Bernard L; Pitois A; Sherratt MJ
Br J Dermatol; 2024 Jun; 191(1):92-106. PubMed ID: 38375775
[TBL] [Abstract][Full Text] [Related]
9. Anti-aging proof of concept study: results and summary.
Bruce S; Karnik J; Dryer L; Burkholder D
J Drugs Dermatol; 2014 Sep; 13(9):1074-81. PubMed ID: 25226008
[TBL] [Abstract][Full Text] [Related]
10. Topical growth factors and home-based microneedling for facial skin rejuvenation.
Quinlan DJ; Ghanem AM; Hassan H
J Cosmet Dermatol; 2022 Aug; 21(8):3469-3478. PubMed ID: 34951101
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of the effect of a topical product containing salicin on the visible signs of human skin aging.
Gopaul R; Knaggs HE; Lephart JF; Holley KC; Gibson EM
J Cosmet Dermatol; 2010 Sep; 9(3):196-201. PubMed ID: 20883292
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of a novel anti-aging topical formulation containing cycloastragenol, growth factors, peptides, and antioxidants.
Weiss RA; Weiss MA
J Drugs Dermatol; 2014 Sep; 13(9):1135-9. PubMed ID: 25226016
[TBL] [Abstract][Full Text] [Related]
13. Novel eye cream containing a mixture of human growth factors and cytokines for periorbital skin rejuvenation.
Lupo ML; Cohen JL; Rendon MI
J Drugs Dermatol; 2007 Jul; 6(7):725-9. PubMed ID: 17763597
[TBL] [Abstract][Full Text] [Related]
14. Nitrogen plasma skin regeneration for the treatment of mild-to-moderate periorbital wrinkles: A prospective, randomized, controlled evaluator-blinded trial.
Theppornpitak N; Udompataikul M; Chalermchai T; Ophaswongse S; Limtanyakul P
J Cosmet Dermatol; 2019 Feb; 18(1):163-168. PubMed ID: 30146783
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation: clinical, profilometric, histologic, ultrastructural, and biochemical evaluations and comparison of three different treatment settings.
Lee SY; Park KH; Choi JW; Kwon JK; Lee DR; Shin MS; Lee JS; You CE; Park MY
J Photochem Photobiol B; 2007 Jul; 88(1):51-67. PubMed ID: 17566756
[TBL] [Abstract][Full Text] [Related]
16. Topically applied physiologically balanced growth factors: a new paradigm of skin rejuvenation.
Sundaram H; Mehta RC; Norine JA; Kircik L; Cook-Bolden FE; Atkin DH; Werschler PW; Fitzpatrick RE
J Drugs Dermatol; 2009 May; 8(5 Suppl Skin Rejuenation):4-13. PubMed ID: 19562882
[TBL] [Abstract][Full Text] [Related]
17. Comparison of microneedle fractional radiofrequency therapy with intradermal botulinum toxin a injection for periorbital rejuvenation.
Jeon IK; Chang SE; Park GH; Roh MR
Dermatology; 2013; 227(4):367-72. PubMed ID: 24280617
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of safety and efficacy of the TriFractional RF technology for treatment of facial wrinkles.
Gold MH; Adelglass J
J Cosmet Laser Ther; 2014 Jan; 16(1):2-7. PubMed ID: 24131069
[TBL] [Abstract][Full Text] [Related]
19. Periorbital area rejuvenation using carbon dioxide therapy.
Paolo F; Nefer F; Paola P; Nicolò S
J Cosmet Dermatol; 2012 Sep; 11(3):223-8. PubMed ID: 22938007
[TBL] [Abstract][Full Text] [Related]
20. Improvement in skin wrinkles using a preparation containing human growth factors and hyaluronic acid serum.
Lee DH; Oh IY; Koo KT; Suk JM; Jung SW; Park JO; Kim BJ; Choi YM
J Cosmet Laser Ther; 2015 Feb; 17(1):20-3. PubMed ID: 25260051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
